Search Results - "Voso, M T"

Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial–mesenchymal transition pathways by Ottone, T., Silvestrini, G., Piazza, R., Travaglini, S., Gurnari, C., Marchesi, F., Nardozza, A. M., Fabiani, E., Attardi, E., Guarnera, L., Divona, M., Ricci, P., Irno Consalvo, M. A., Ienzi, S., Arcese, R., Biagi, A., Fiori, L., Novello, M., Mauriello, A., Venditti, A., Anemona, L., Voso, M. T.

“…Extramedullary (EM) colonization is a rare complication of acute myeloid leukemia (AML), occurring in about 10% of patients, but the processes underlying…”
Get full text

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine by Valencia, A, Masala, E, Rossi, A, Martino, A, Sanna, A, Buchi, F, Canzian, F, Cilloni, D, Gaidano, V, Voso, M T, Kosmider, O, Fontenay, M, Gozzini, A, Bosi, A, Santini, V

“…The nucleoside analog azacitidine (AZA) is used in the treatment of myelodysplastic syndromes (MDS), but 30–40% of patients fail to respond or relapse after…”
Get full text

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia by Alfonso, V., Iaccarino, L., Ottone, T., Cicconi, L., Lavorgna, S., Divona, M., Cairoli, R., Cristiano, A., Ciardi, C., Travaglini, S., Falconi, G., Hasan, S. K., Venditti, A., Arcese, W., Voso, M. T., Lo-Coco, F.

Get full text

Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas by Hohaus, S., Giachelia, M., Massini, G., Mansueto, G., Vannata, B., Bozzoli, V., Criscuolo, M., D'Alò, F., Martini, M., Larocca, L.M., Voso, M.T., Leone, G.

“…Levels of cell-free circulating DNA have been correlated to clinical characteristics and prognosis in patients with cancers of epithelial origin, while there…”
Get full text

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes by Efficace, F., Gaidano, G., Sprangers, M., Cottone, F., Breccia, M., Voso, M.T., Caocci, G., Stauder, R., Di Tucci, A.A., Sanpaolo, G., Selleslag, D., Angelucci, E., Platzbecker, U., Mandelli, F.

“…The main objective of this study was to assess preferences for involvement in treatment decisions and requests for prognostic information in newly diagnosed…”
Get full text

The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia by Travaglini, S., Gurnari, C., Antonelli, S., Silvestrini, G., Noguera, N. I., Ottone, T., Voso, M. T.

“…Data derived from high-throughput sequencing technologies have allowed a deeper understanding of the molecular landscape of Acute Myeloid Leukemia (AML),…”
Get full text

Bone Marrow Microenvironment Involvement in t-MN: Focus on Mesenchymal Stem Cells by Falconi, Giulia, Galossi, E, Hajrullaj, H, Fabiani, E, Voso, M T

“…Therapy-related myeloid neoplasms (t-MN) are a late complication of cytotoxic therapy (CT) used in the treatment of both malignant and non-malignant diseases…”
Get full text

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine by Voso, M T, Fabiani, E, Piciocchi, A, Matteucci, C, Brandimarte, L, Finelli, C, Pogliani, E, Angelucci, E, Fioritoni, G, Musto, P, Greco, M, Criscuolo, M, Fianchi, L, Vignetti, M, Santini, V, Hohaus, S, Mecucci, C, Leone, G

Get full text

Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT by Arcaini, L., Burcheri, S., Rossi, A., Paulli, M., Bruno, R., Passamonti, F., Brusamolino, E., Molteni, A., Pulsoni, A., Cox, M.C., Orsucci, L., Fabbri, A., Frezzato, M., Voso, M.T., Zaja, F., Montanari, F., Merli, M., Pascutto, C., Morra, E., Cortelazzo, S., Lazzarino, M.

“…Background: Hepatitis C virus (HCV) infection is frequently associated with B-cell non-Hodgkin's lymphomas. We investigated the prevalence of HCV infection in…”
Get full text

Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes by HASAN, S. K, BUTTARI, F, BERNARDI, G, CENTONZE, D, LO-COCO, F, OTTONE, T, VOSO, M. T, HOHAUS, S, MARASCO, E, MANTOVANI, V, GARAGNANI, P, SANZ, M. A, CICCONI, L

“…Single nucleotide polymorphisms (SNPs) in double-strand break repair genes may alter DNA repair capacity and, in turn, confer predisposition to leukemia. We…”
Get full text

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma by Hohaus, S, Giachelia, M, Di Febo, A, Martini, M, Massini, G, Vannata, B, D'Alo', F, Guidi, F, Greco, M, Pierconti, F, Larocca, LM, Voso, MT, Leone, G

“…Background: In Hodgkin's lymphoma (HL), the production of cytokines by Reed–Sternberg cells and the surrounding tissue is thought to contribute to the biology…”
Get full text

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes by Voso, MT, Fabiani, E, D'Alo', F, Guidi, F, Di Ruscio, A, Sica, S, Pagano, L, Greco, M, Hohaus, S, Leone, G

“…Background: Polymorphisms in genes involved in detoxification and DNA-repair pathways may modify the individual's risk for genomic damage, and, as a…”
Get full text

Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia by Voso, M T, Hohaus, S, Guidi, F, Fabiani, E, D'Alò, F, Groner, S, Späth, D, Doehner, K, Leone, G, Doehner, H, Schlenk, R F

“…Glutathione S -transferases (GSTs) are phase II detoxification enzymes involved in the metabolism of carcinogens and anticancer drugs, known also to interact…”
Get full text

Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy by Fianchi, L, Colosimo, C, De Luca, A, Pompucci, A, Cattani, P, Voso, M T, LaRocca, L M, Leone, G, Pagano, L

Get full text

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS by Kuendgen, A., Nomdedeu, M., Tuechler, H., Garcia-Manero, G., Komrokji, R. S., Sekeres, M. A., Della Porta, M. G., Cazzola, M., DeZern, A. E., Roboz, G. J., Steensma, D. P., Van de Loosdrecht, A. A., Schlenk, R. F., Grau, J., Calvo, X., Blum, S., Pereira, A., Valent, P., Costa, D., Giagounidis, A., Xicoy, B., Döhner, H., Platzbecker, U., Pedro, C., Lübbert, M., Oiartzabal, I., Díez-Campelo, M., Cedena, M. T., Machherndl-Spandl, S., López-Pavía, M., Baldus, C. D., Martinez-de-Sola, M., Stauder, R., Merchan, B., List, A., Ganster, C., Schroeder, T., Voso, M. T., Pfeilstöcker, M., Sill, H., Hildebrandt, B., Esteve, J., Nomdedeu, B., Cobo, F., Haas, R., Sole, F., Germing, U., Greenberg, P. L., Haase, D., Sanz, G.

“…In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related…”
Get full text

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies by Noguera, N., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., Arcese, W., Voso, M.

“…This review highlights new findings that have deepened our understanding of the mechanisms of leukemogenesis, therapy and resistance in acute promyelocytic…”
Get full text

The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression by LIU, H. B, VOSO, M. T, GUMIERO, D, DUONG, J, MCKENDRICK, J. J, DEAR, A. E

“…A combination of demethylating agents and histone deacetylase inhibitors (HDACi) has been proposed as a novel therapy in leukemia and myelodysplasia. In HL-60…”
Get full text

PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy by Cicconi, L, Divona, M, Ciardi, C, Ottone, T, Ferrantini, A, Lavorgna, S, Alfonso, V, Paoloni, F, Piciocchi, A, Avvisati, G, Ferrara, F, Di Bona, E, Albano, F, Breccia, M, Cerqui, E, Sborgia, M, Kropp, M G, Santoro, A, Levis, A, Sica, S, Amadori, S, Voso, M T, Mandelli, F, Lo-Coco, F

“…The APL0406 study showed that arsenic trioxide (ATO) and all -trans retinoic acid (ATRA) are not inferior to standard ATRA and chemotherapy (CHT) in newly…”
Get full text

Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression by Rivalta, B, Attardi, E, Cifaldi, C, Rosti, V, Pacillo, L, Hajrullaj, H, Di Cesare, S, Amodio, D, Algeri, M, Luciani, M, Barzaghi, F, Finocchi, A, Di Matteo, G, Aiuti, A, Locatelli, F, Voso, M T, Palumbo, G, Cancrini, C

Get full text

Therapy-related leukemia and myelodysplasia: susceptibility and incidence by Leone, Giuseppe, Pagano, Livio, Ben-Yehuda, Dina, Voso, Maria Teresa

“…From Istituto di Ematologia, Università Cattolica S. Cuore, Rome, Italy (GP, LP, MTV); Department of Hematology, Hadassah University Hospital, Jerusalem,…”
Get full text